# clm_8E5607E4B59B

subject: Amgen (/record/amgen.md)  
predicate: cash_and_equivalents  
value: 9,445,000,000 United States dollar  
valid_from: 2025-09-30  
valid_to: 2025-12-31  
published: 2025-11-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_F9355A194FAC  
last_updated: 2026-11-08  
cite: AsOf. "Amgen cash and equivalents: 9,445,000,000 United States dollar", as of 2025-09-30 (until 2025-12-31). Claim clm_8E5607E4B59B, https://asof.is/claim/clm_8E5607E4B59B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/0000318154-25-000072-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-11-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/0000318154-25-000072-index.htm (primary, SEC EDGAR 10-Q Q3 FY2025, published 2025-11-05)

## Supersedes

- [Amgen](/record/amgen.md) | cash_and_equivalents | 8,028,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_8E5607E4B59B](/claim/clm_8E5607E4B59B.md) | [clm_C3AA215549F9](/claim/clm_C3AA215549F9.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.